An interventional study of AI-Driven Rehabilitation Program and Traditional Physical Therapy Program in Low Back Pain and Low Back Dysfunction, sponsored by Cairo University. Recruiting at 1 site in Egypt. Open to participants aged 18 Years to 45 Years. Per ClinicalTrials.gov, last updated 2026-10-21.
Sponsored by Cairo University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 74 studies in Low Back Pain by Cairo University — 33 open to participants now, 33 under way, none of them phase 3. Low Back Pain · Cairo University.
Among the 74 studies in Low Back Pain by Cairo University, this one is the 11th largest by planned enrollment of the 65 interventional ones that give a count, is one of 9 that started in 2026, is one of 65 with no phase, reaches primary completion later than 28 of the 32 other live ones, and was the 72nd registered.
2,930 studies on the registry are indexed under Low Back Pain; 581 are open to participants now.
Browse Low Back Pain studies →33 of the 74 studies in Low Back Pain by Cairo University are open now, in 2 countries. Recruiting first, the newest first:
Cairo University · Sites in Egypt
Ages 20–55
Cairo University · Sites in Egypt
Ages 20–25 · Men only
Cairo University · Sites in Egypt
Ages 18–65
Cairo University · Sites in Egypt
Ages 18–24 · Women only
Cairo University · Sites in Egypt
Ages 25–45
By country, each count listing its studies:
Of the 332 Low Back Pain studies recruiting now, 93 (28%) set no upper age limit and 209 (63%) stop at 75 or younger; 8 take children under 18; 46 take healthy volunteers.
This study: 18 Years to 45 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
74 studies; the count open now beside each. This study's row is marked.
First in 2012; this study’s year is marked. 9 started in 2026.
This study's planned enrollment of 68 is above the median of 60 across 2,369 interventional studies indexed under Low Back Pain.
Median enrollment 60 across the 65 interventional studies, 68 across the 9 observational. Of the 33 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
Cairo University is the lead sponsor of 4,967 studies on the registry; 1,474 are open to participants now.
Of its 37 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.
5 of the studies in Low Back Pain by Cairo University that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07749833Cairo UniversityEFFICACY OF ARTIFICIAL INTELLIGENCE DRIVEN PROGRAM VERSUS TRADITIONAL PHYSICAL THERAPY PROGRAM IN PATIENTS WITH LOW BACK DYSFUNCTION | 2026-12 |
| NCT06280989Cairo UniversityEffect of Kinesio Taping Versus Myofascial Release on Menstrual Low Back Pain | 2026-12 |
| NCT07876960Cairo UniversityEffects of Virtual Reality Exergames Versus Spinal Manipulation in Chronic Nonspecific Low Back Pain | 2026-12-20 |
| NCT07683676Cairo UniversityKinetic Control Training Versus Core Stability Exercises on Proprioception and Spatiotemporal Gait Parameters in Chronic Non-specific Low Back Pain | 2027-05-01 |
| NCT07825298Cairo UniversityTECAR Therapy and Chronic Low Back Pain | 2027-08-20 |
Add all 5 to your calendar (.ics) → With an account.
Among the 74 studies in Low Back Pain by Cairo University, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Low back dysfunction is one of the most common musculoskeletal disorders and is associated with pain, disability, and reduced quality of life. Artificial intelligence (AI) has emerged as a promising tool to support personalized rehabilitation by improving exercise prescription, monitoring adherence, and providing real-time feedback. This randomized controlled trial aims to compare the effectiveness of an AI-driven rehabilitation program with a traditional physical therapy program in patients with low back dysfunction. Primary outcomes include pain intensity, functional disability, and quality of life. The findings may provide evidence regarding the role of AI-assisted rehabilitation in improving clinical outcomes.
This study is a prospective randomized controlled trial designed to evaluate the efficacy of an artificial intelligence-driven rehabilitation program compared with a traditional physical therapy program in patients with low back dysfunction. Eligible participants will be randomly allocated into two groups. The experimental group will receive an AI-driven rehabilitation program, while the control group will receive a standardized traditional physical therapy program. Clinical outcomes will be assessed before and after the intervention using validated outcome measures for pain, functional disability, quality of life, and other variables specified in the study protocol. The study aims to determine whether integrating artificial intelligence into rehabilitation provides superior clinical outcomes compared with conventional physical therapy.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants will receive an artificial intelligence-driven rehabilitation program including personalized exercise prescription, progression, and monitoring according to the study protocol.
Other: AI-Driven Rehabilitation Program
Participants will receive a standardized traditional physical therapy rehabilitation program according to the study protocol.
Other: Traditional Physical Therapy Program
A personalized rehabilitation program guided by artificial intelligence, including individualized exercise prescription and progression.
A conventional physical therapy rehabilitation program delivered according to the study protocol
Pain Intensity
Pain intensity measured using the Visual Analogue Scale (VAS), a 10-cm self-reported pain scale ranging from 0 (no pain) to 10 (worst imaginable pain).
Time frame: Baseline and immediately post intervention 6 weeks of treatment.
Functional Performance
Functional performance measured using the Back Performance Scale (BPS). The total score ranges from 0 to 15, with higher scores indicating greater functional limitation.
Time frame: Baseline and after 6 weeks.
Cost-effectiveness
Cost-effectiveness assessed using the Incremental Cost-Effectiveness Ratio (ICER), based on total costs and clinical effectiveness of the AI-driven and traditional physical therapy programs,including direct medical costs, intervention-related costs, and healthcare utilization costs.
Time frame: After completion of the 6-week intervention.
Lumbar Range of Motion
Lumbar range of motion assessed using the Back Range of Motion (BROM II) device measuring lumbar flexion, extension, lateral flexion, and rotation.
Time frame: Baseline and after 6 weeks.
Plan to share: No — Individual participant data will not be publicly shared to protect participant confidentiality and privacy.
No publications or documents are linked to this record.
Started Aug 2026 (actual). Primary completion is estimated for Dec 2026, 4 months after the start.
Of 1,234 non-industry interventional studies with no phase under Low Back Pain, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 26. This study's planned 4 months is below that.
Counting every sponsor, half of 1,290 studies reached it within 11 months; a quarter within 5 and three quarters within 27.
Completion moved once since we started tracking on Sep 25, 2026: Jan 2027 → May 2027, on Oct 21, 2026.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.